Please login to the form below
Moderna
This page shows the latest Moderna news and features for those working in and with pharma, biotech and healthcare.
Merck’s Keytruda combination receives CHMP recommendation for biliary tract cancer
There are also currently more than 1, 600 trials studying the therapy, including one evaluating it in combination with Merck and Moderna’s investigational skin cancer vaccine.
Latest news
-
Moderna and CEPI enter pandemic preparedness partnership
Moderna has announced a strategic partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) to accelerate the development of vaccines against future viral disease outbreaks. ... CEPI researchers will send cutting-edge computational
-
Alliance for mRNA Medicines launched to accelerate global innovation
The potential of the approach was brought to the fore during the COVID-19 pandemic and mRNA vaccines, including those from Moderna and Pfizer/BioNTech, have now been used globally to
-
Pfizer and BioNTech’s COVID-19/flu combination vaccine shows promise in phase 1/2 study
The readout comes just a few weeks after Moderna announced promising results from a phase 1/2 trial of its own mRNA COVID-19/flu combination vaccine. ... Moderna has also said it is planning to begin a phase 3 trial of its candidate this year, adding
-
Merck’s Keytruda granted FDA approval for expanded use in lung cancer
There are also currently more than 1, 600 trials studying the therapy, including one evaluating it in combination with Merck and Moderna’s investigational skin cancer vaccine.
-
Differences in immune responses could optimise future COVID-19 vaccines
number of doses of the Moderna vaccine, the researchers analysed the immunity that they had developed.
More from news
Approximately 98 fully matching, plus 163 partially matching documents found.
Latest Intelligence
-
Turning the UK into an mRNA superpower: what would it take?
It has also signed strategic partnerships with Moderna and BioNTech, global leaders in this technology.
-
The state of pharma customer experience
Meanwhile, at the bottom of the CXQ rankings, it’s perhaps not a surprise to see Moderna and BioNTech take the last and second-to-last slots respectively. ... navigating a still-changing commercial environment will have added to Moderna’s CX
-
Customers, content and change
The vaccine customer. One of the stories most embedded in the health crisis was from Moderna’s Darius Hughes. ... Overcoming that hurdle allowed Moderna to distribute some three million doses of its vaccine to patients in the UK within a month.
-
Fair representation in research matters to the sector and to society
In the US, both Pfizer and Moderna worked with community organisations to increase representation in the COVID-19 vaccine trials.
-
The new reality of building a corporate brand in pharma
Until the likes of Pfizer, AstraZeneca and Moderna started to have their coronavirus vaccines approved, the companies behind the medicines were rarely recognised by the public. ... The pharmaceutical and biotech company Moderna was virtually unknown to
More from intelligence
Approximately 1 fully matching, plus 14 partially matching documents found.
Latest appointments
-
Ex-Roche CMO Sandra Horning joins Gilead’s board of directors
Horning has also recently joined the board of directors at Moderna, a clinical-stage biotechnology company based in Cambridge, Massachusetts.
-
Tony de Fougerolles joins Evox Therapeutics as CEO
Prior to this, he was chief scientific officer at Moderna Therapeutics and has held the same role at Tolerx.
-
Medicxi appoints former GSK chair Moncef Slaoui
Dr Slaoui takes on the role alongside his other board positions, which include chairman of the board at Galvani Bioelectronics, and on the boards of Artisan Biosciences, Moderna Therapeutics and Sutovax.
-
MIT chief financial officer joins Moderna Therapeutics
US-based biotech Moderna Therapeutics has appointed Israel Ruiz to its board of directors to serve as audit committee chair. ... Dr Noubar Afeyan, co-founder and chairman of Moderna Therapeutics, said: “We are delighted to welcome Israel to Moderna's
-
PureTech Health appoints chief scientific officer
Bringing over 30 years of clinical development experience to the role, he joins from Moderna Therapeutics where he most recently served as president and chief scientific officer.
More from appointments
Approximately 3 fully matching, plus 6 partially matching documents found.
Latest from PMHub
-
The future of nanomedicine regulation
In their latest blog, Hanover Brussels Alicia Rojo Santos and Pilar Serrano explores why the sector expecting to set off following the success of the Pfizer and Moderna SARS-CoV-2 ... With the emergency use authorisation and success of the Pfizer and
-
Clinical trials and the diversity principle
The following month, it happened again. Cambridge, Massachusetts-based Moderna said it had slowed enrolment in its phase 3 COVID-19 vaccine trial to ensure they were getting a representative population. ... Moderna effectively sacrificed potential sales,
-
Mistrust in medical research: a patient perspective
15]. In fact, Moderna slowed down recruitment for its COVID-19 vaccine trial specifically to address a shortfall in recruitment from ethnically diverse populations for an illness that has been shown
-
Is the world ready for a COVID-19 vaccine?
Since then, other good news has followed, with collaborations, including Moderna and AstraZeneca, publishing similarly positive results. ... Since this initial announcement, other good news in vaccine development has followed, with companies and
-
Hanover Communications
In their latest blog, Hanover Brussels Alicia Rojo Santos and Pilar Serrano explores why the sector expecting to set off following the success of the Pfizer and Moderna SARS-CoV-2 ... Since then, other good news has followed, with collaborations,
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
Subscribe to our email news alerts
- Roche to acquire Carmot Therapeutics in deal worth up to $3.1bn
- Eli Lilly’s Jaypirca granted FDA accelerated approval for non-Hodgkin lymphomas
- UK-India research project trialling easy-to-use UTI test to support fight against AMR
- Cancer Research UK and Guardant collaborate to advance cancer detection and treatment
- Give the gift of positive change
- Apple Vision Pro: challenges and opportunities for pharma
No results were found
PMHub
11 London
We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our...
Latest intelligence
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
